Company: TVRD
Filing Date: 2025-10-07
Form Type: S-1/A
Source: 0001104659-25-097519
Chunk: 272

Company: Tvardi Therapeutics, Inc.
Filing Date: 2025-10-07
Form: S-1/A
Chunk 272
---
 Notes. |

| (4) | The $250,000 aggregate principal amount of Convertible Notes purchased by Firepit Partners, LP converted into 11,183 shares of our common stock upon the closing of the Merger. Wallace Hall was a member of Legacy Tvardi’s board of directors and is the general partner of Firepit Partners, LP. Mr. Hall has sole voting and dispositive power over of any shares received by Firepit Partners, LP. in the conversion of such Convertible Notes. |

| (5) | Consisted of $13,375,000 in an aggregate principal amount of Convertible Notes purchased by Solas Tvardi Sidecar, LLC, which were converted into 598,288 shares of our common stock upon the closing of the Merger. Upon the closing of the Merger and as a result of the conversion of the Convertible Notes into shares of our common stock, entities affiliated with Solas BioVentures became greater than 5% stockholders of our common stock. |

Series B Preferred Stock Financing In multiple closings held between June 3, 2021 and June 17, 2021, Legacy Tvardi issued and sold an aggregate of 20,055,539 shares of its Series B redeemable convertible preferred stock, $0.001 par value per share (the “Series B Preferred Stock”), at a purchase price of $3.8095 per share for an aggregate purchase price of $74,418,281.20. Immediately prior to the closing of the Merger, the Series B Preferred Stock was converted into shares of Legacy Tvardi common stock, which were then exchanged for shares of our common stock based upon the Exchange Ratio upon the closing of the Merger. The following table summarizes the Series B Preferred Stock purchased by holders of more than 5% of Legacy Tvardi’s capital stock and entities affiliated with its executive officers and members of its board of directors.

| ​                                      | ​ |         ​ | ​ |             ​ |
| ​                                      | ​ | Shares of | ​ |             ​ |
| ​                                      | ​ |  Series B | ​ |             ​ |
| ​                                      | ​ | Preferred | ​ |     Aggregate |
| ​                                      | ​ |     Stock | ​ |      Purchase |
| ​                                      | ​ | Purchased | ​ |         Price |
| Participants(1)                        |   |        -# |   |            -$ |
| Entities affiliates with Slate Path(2) | ​ | 5